Los Angeles Capital Management LLC lessened its position in MetLife, Inc. (NYSE:MET – Free Report) by 92.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,525 shares of the financial services provider’s stock after selling 57,770 shares during the quarter. Los Angeles Capital Management LLC’s holdings in MetLife were worth $373,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Carmichael Hill & Associates Inc. lifted its holdings in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares in the last quarter. Wolff Wiese Magana LLC lifted its holdings in MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares in the last quarter. Fortitude Family Office LLC lifted its holdings in MetLife by 177.3% during the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after buying an additional 266 shares in the last quarter. Bank & Trust Co bought a new stake in MetLife during the 2nd quarter valued at about $39,000. Finally, Crewe Advisors LLC lifted its holdings in MetLife by 602.5% during the 2nd quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock valued at $39,000 after buying an additional 482 shares in the last quarter. Institutional investors own 89.81% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the stock. Morgan Stanley decreased their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a report on Monday, August 19th. Barclays cut their target price on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday, October 31st. TD Cowen assumed coverage on shares of MetLife in a research report on Wednesday, October 9th. They set a “buy” rating and a $97.00 target price on the stock. StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th. Finally, Piper Sandler raised their target price on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Fourteen investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $88.46.
MetLife Stock Up 0.9 %
Shares of MetLife stock opened at $83.33 on Monday. The company has a market cap of $57.70 billion, a P/E ratio of 16.80, a PEG ratio of 0.76 and a beta of 1.05. MetLife, Inc. has a 52-week low of $61.61 and a 52-week high of $86.94. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm’s 50 day moving average price is $81.60 and its 200-day moving average price is $75.62.
MetLife Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be given a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.62%. The ex-dividend date is Tuesday, November 5th. MetLife’s dividend payout ratio is presently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Stock Market Upgrades: What Are They?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Roth IRA Calculator: Calculate Your Potential Returns
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- The 3 Best Retail Stocks to Shop for in August
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.